Covid-19 Drugs

COVID-19 Drugs: University Of Liverpool Phase 1a Clinical Trial Of Using Nitazoxanide To Treat COVID-19 Shows Potential. Phase 1b/2a Initiated

Source: COVID-19 Drugs Sep 16, 2021 3 years ago

COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...

BREAKING! Randomized Clinical Trial Findings Confirms That Early Treatment With Fluvoxamine Reduces Risk Of COVID-19 Severity And Mortality

Source: COVID-19 Drugs-Fluvoxamine Sep 06, 2021 3 years ago

COVID-19 Drugs: Results from the TOGETHER multi-institutional, multi-country randomized platform clinical trials of various repurposed drugs to treat COVID-19 has shown that treatment with fluvoxamine (100mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization. The institutions ...

University Of California Researchers Exploring Using Ethacridine-An Abortion Drug To Inhibit SARS-CoV-2 By Inactivating Viral Particles

Source: COVID-19 Drugs Sep 04, 2021 3 years ago

COVID-19 Drugs: Researchers from the University of California-San Francisco along with support from Stanford University are exploring the use of the abortion drug Ethacridine to inhibit SARS-CoV-2 by inactivating viral particles and to assess its potential as a prophylaxis and also therapeutic agent to treat COVId-19. Their study findings were published in the peer reviewed journal: PLOS Pathogen...

Breakthrough! University Of Alabama Study Finds That The Drug To Treat Blood Cancer-Venetoclax Could Be Repurposed To Reverse Lung Fibrosis Especially In COVID!

Source: Pulmonary Fibrosis Sep 01, 2021 3 years ago

A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials. Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...

COVID-19 Drugs: Cheap Heart Drug-Metoprolol Aids In Treating Severe COVID-19 Says Study Published In Journal of the American College of Cardiology

Source: COVID-19 Drugs Sep 01, 2021 3 years ago

Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Spain and the IIS-Fundación Jiménez Díaz University Hospital-Spain have in a new clinical study discovered that metprolol- a cheap drug widely used to treat cardiovascular disease, is beneficial in treating severely ill COVID-19 patients. Metoprolol, sold under the brand name Lopressor, amo...

BREAKING! American and German Study Shows That Heartburn Drug Famotidine With Aspirin Prevents COVID-19 Disease Severity and Mortality

Source: COVID-19 Drugs Aug 21, 2021 3 years ago

COVID-19 Drugs: A detailed meta-analytical study by researchers from the University of Virginia-USA, Humboldt-Universität zu Berlin-Germany, Freie Universität-Germany and Berlin Institute of Health, of previous research findings including clinical trials has revealed that the heartburn drug famotidine used alongside Aspirin has the potential to prevent disease severity a...

BREAKING! Fluvoxamine- An ‘Inexpensive’ Anti-Depressant Emerging As A Leading Drug Candidate To be Repurposed To Treat COVID-19

Source: COVID-19 Drugs-Fluvoxamine Aug 14, 2021 3 years ago

COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19. Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa. Fluvoxamine, sold under the brand name Luvox among others, is an antid...

Stop Using Ivermectin As It Does Not Work On The New SARS-CoV-2 Variants!

Source: COVID-19 Drugs Aug 13, 2021 3 years ago

Despite so many small randomized clinical trials and observational studies that showed Ivermectin could be used to treat COVID-19 during the early stages of the COVID-19 pandemic, physicians, researchers and individuals should stop attempting to treat COVID-19 with Ivermectin as the drug as no efficacy against most of the new variants that are currently dominating various countries. Thailand Medi...

Yale Study Reveals That Enzyme Present In SARS-Cov-2 Known As Coronavirus 3′-5′ Exoribonuclease (ExoN) Is Responsible For Antiviral Drug Resistance

Source: COVID-19 Therapeutics Aug 09, 2021 3 years ago

COVID-19 Therapeutics: A new research led by scientists from Yale University along with other experts from University of Minnesota and Iowa State University has found that a crucial enzyme known as the Coronavirus 3′–5′ exoribonuclease (ExoN) promotes antiviral resistance hence making many identified drugs such as remdesivir, ivermectin and even identified antiviral phytochemical...

BREAKING! Salicylanilides In Anti-Worm Drugs Like Niclosamide Inhibits SARS-CoV-2 Replication And Suppresses Inflammation Causing Cytokines

Source: COVID-19 Drugs Aug 07, 2021 3 years ago

COVID-19 Drugs: A new mouse based vivo study by researchers from the Scripps Research Institute-California along with scientist from the University of Texas and Sorrento Therapeutics Inc.-California have found that salicylanilides which are active pharmaceutical ingredients (APIs) found in drugs used to treat tapeworm infestations demonstrated efficacy in terms of inhibiting the SARS-CoV-2 coronav...

COVID-19 Drugs: Fenofibrate-A Cholesterol Lowering Drug Reduces SARS-CoV-2 Infection By Up To 70 Per Cent According to British and Italian Scientists

Source: COVID-19 Drugs Aug 07, 2021 3 years ago

COVID-19 Drugs: Scientists from the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy have demonstrated that the licensed cholesterol lowering drug fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory. Importantly, reduction of infection was obtained using conce...

COVID-19 Drugs: New In Vitro Study Shows That The High Blood Pressure Drug Losartan Inhibits SARS-CoV-2 Replication

Source: COVID-19 Drugs Aug 04, 2021 3 years ago

COVID-19 Drugs: A new in vitro study conducted by researchers from University of Georgia-US and Shahid Beheshti University-Iran has found that the common high pressure drug called Losartan is able to inhibit SARS-CoV-2 coronavirus replication. Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. Losartan belongs to a gr...

COVID-19 Therapeutics: MicroRNAs From Plants And Even Humans Might be The Holy Grail To Stopping The SARS-CoV-2 Crisis

Source: miRNAs and SARS-CoV-2 Aug 02, 2021 3 years ago

COVID-19 Therapeutics: Researchers from Gujarat University inspired by Thailand Medical News call to focus on Phytochemicals and microRNAs as solutions to containing the SARS-CoV-2 pandemic have in a new study utilizing computational workflow, identified potential cellular miRNA candidates that are potent in providing antiviral defense against SARS-CoV-2 infection. The study team designed a syste...

COVID-19 Drugs: German Study Confirms The Antiviral Effects Of Budesonide Against The SARS-CoV-2 Coronavirus And Even Against Emerging Variants

Source: COVID-19 Drugs-Budesonide Jul 29, 2021 3 years ago

Another study finding has emerged proving the antiviral effects of Budesonide when used either as an inhaler or as a nasal spray. German researchers from the Ruhr-University Bochum and also from the European Virus Bioinformatics Center (EVBC) based in Jena-Germany have in a new study confirmed the viral effects of Budesonide against the wildtype SARS-CoV-2 coronavirus and even against the ...

Chinese Study Finds That Lectins Derived From Indian Lentils Or Dhal Exhibit Antiviral Properties Against The SARS-CoV-2 Coronavirus.

Source: COVID-19 Antivirals Jul 29, 2021 3 years ago

A new study by scientists from the National Institutes for Food and Drug Control (NIFDC)-China has found that lectins derived from lentils (Lens culinaris)- a staple in Indian cuisine often known as dhal, exhibits antiviral properties against the SARS-CoV-2 coronavirus. The study findings were published in the peer reviewed journal: Emerging Microbes and Infection. https://www.tandfonline.com/doi...

BREAKING! British Study Claims An Abnormal Antibody Response Is What Is Causing Blood Clots In Severe COVID-19 Patients

Source: Breaking COVID-19 News Jul 28, 2021 3 years ago

A new study by researchers from the University of Reading, Reading, United Kingdom has found that inflammation and blood clotting seen in very severe cases of COVID-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs. According to the study team a subset of patients with COVID-19 typically become critically ill, suffering from severe ...

American Study Shows That Plant Flavonols And Dihydroflavonols Show Potential As Antivirals As They Inhibit Mpro Of SARS-Cov-2 In Vitro

Source: Herbs and Phytochemicals for COVID-19. Jul 24, 2021 3 years ago

As the COVID-19 pandemic fast accelerates into a more catastrophic mode and there are still no effective antivirals to date plus antibody therapies as well as vaccines are beginning to show signs of being defeated by the new emerging variants, there is a dire need for effective therapeutics against the SARS-CoV-2 coronavirus and various study teams around the world are frantically searching for pr...

Various Studies Are Showing That Reactivation Of Dormant Epstein-Barr Virus Could Be What Is Responsible For COVID Severity As Well As Long COVID

Source: Epstein-Barr virus and COVID-19 Jul 22, 2021 3 years ago

A number of studies are emerging that indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. It has been found that Coronavirus disease 2019 (COVID-19) patients sometimes experience long-term symptoms following resolution of acute disease, including fatigue, brain fog, and rashes. One study published ...

BREAKING! Study Finds That N-Acetylneuraminic Acid And Its Analogs Can Be Used To Prevent Adverse Reactions Due To COVID-19 Infection Or Vaccines

Source: COVID-19 Drugs Jul 19, 2021 3 years ago

A new study by biotech researchers from Hangzhou-China involved in a development of new drug formulation has found that N-Acetylneuraminic Acid (NANA) and its analogs such as acetylneuraminic acid methyl ester (NANA-Me) are able prevent and also treat adverse reactions caused by COVID-19 infections and also by COVID-19 vaccines. Edible Bird's Nest- A Good Source Of N-Acetylneuramin...

COVID-19 Drugs: University Of California Study Confirms That Statins Used To Reduce Cholesterol Levels Can Also Decrease COVID-19 Mortality

Source: COVID-19 Drugs-Statins Jul 16, 2021 3 years ago

COVID-19 Drugs: A new study by researchers from the University of California-San Diego School Of medicine-USA has confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. According to the study team, statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of the COVID-19 disease, in which organ dysfunction i...

COVID-19 Therapeutics: Japanese Study Shows That Short Chain Fatty Acids (SCFAs) Could Serve To Contain SARS-CoV-2 By Downregulating ACE2

Source: COVID-19 Therapeutics Jul 15, 2021 3 years ago

COVID-19 Therapeutics: A new study by researchers from University of Fukui-Japan shows that Short Chain Fatty Acids (SCFAs) could be used as potential therapeutics to treat COVID-19 and also to act as a prophylaxis. The researchers showed that SCFAs could downregulate ACE2 in epithelial cells. According to the study team inflammatory endotype affects ACE2 expression in the nasal mucosa and influe...

COVID-19 Clinical Care: Canadian Doctors Say That Early Usage Of Anticoagulants Like Heparin In Moderate COVID-19 Patients Reduces Mortality

Source: COVID-19 Clinical Care-Heparin Jul 14, 2021 3 years ago

COVID-19 Clinical Care: A new study undertaken by medical researchers from the St. Michael's Hospital, a treatment site of Unity Health Toronto and the University of Vermont Larner College of Medicine indicates that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of...

American Study Confirms That Aspirin Use Is Associated With Decreased Mortality Risk In COVID-19 Patients

Source: COVID-19 Drugs-Aspirin Jul 14, 2021 3 years ago

Aspirin-COVID-19: A detailed systematic review and meta-analysis study by researchers from the Michigan State University, USA has found that aspirin usage is associated with a significant reduction in overall and in-hospital mortality rates. The current COVID-19 pandemic has so far caused more than 4.05 million deaths and far more are expected to die in coming surges. The benefits of aspir...

BREAKING! French Study Shows That Mannose-Specific Lectins From Plants, Fungi, Algae And Cyanobacteria Can Prevent Various Coronavirus Transmissions Including SARS-CoV-2

Source: Coronavirus News Jul 03, 2021 3 years ago

Coronavirus News: A new study by researcher from Université Paul Sabatier-France, Ecole Nationale Vétérinaire d’Alfort-France, Université Grenoble Alpes-France and also involving scientist from Ghent University-Belgium has shown that mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of ...

COVID-19 Drugs: Usage Of Pyrimidine Biosynthesis Inhibitors Such As Mycophenolate, Azathioprine And Leflunomide In Conjunction With Nucleoside Analogs Inhibits SARS-CoV-2

Source: COVID-19 Drugs Jul 03, 2021 3 years ago

COVID-19 Drugs: A new study by American and Swiss researchers from University of Pennsylvania , University of Maryland, National Institutes of Health-USA and Epithelix-Switzerland demonstrates that usage of pyrimidine biosynthesis inhibitors such as Mycophenolate, Azathioprine And Leflunomide in conjunction with nucleoside analogs (Examples of such nucleoside analogs include Remdesivir and M...

COVID-19 Treatments: Metabolic activators Such As N-Acetyl-L-Cysteine, L-Carnitine Tartrate, Nicotinamide Riboside, L-Serine Can Reduce Recovery Time In COVID-19 Patients

Source: COVID-19 Drugs And Supplements Jul 01, 2021 3 years ago

COVID-19 Treatments: A new study by researchers from the Royal Institute of Technology-Sweden, University of Health Sciences-Turkey, Istanbul Technical University-Turkey, Atatürk University-Turkey, Chalmers University of Technology-Sweden, University of Gothenburg and Sahlgrenska University Hospital-Sweden and Istanbul Medipol University-Turkey has found that metabolic activators such as nico...

COVID-19 Drugs: Study Published In Journal Of The Heart Rhythm Society Warns That Remdesivir Can Cause Dangerously Low Heart Rate In COVID-19 Patients

Source: COVID-19 Drugs Jun 30, 2021 3 years ago

Remdesivir the controversial drug that was deemed to be ineffective in WHO’S SolidarityTrial (https://www.thailandmedical.news/news/latest-who-s-solidarity-drug-trial-shows-that-remdesivir-is-not-the-least-effective-in-treating-covid-19) but is still being approved as a drug to treat COVID-19 under EUA status in the United States by the no longer credible US FDA is now facing more backlash a...

COVID-19 Drugs: Canadian COLCORONA Study Shows That Colchicine Can Reduce Certain Complications Of COVID-19

Source: COVID-19 Drugs May 31, 2021 4 years ago

COVID-19 Drugs: Canadian researchers from the Montreal Heart Institute (MHI) and the Université de Montréal announced the clinical trial findings of the COLCORONA study (NCT04322682), which was a phase 3, randomized, double-blind, adaptive, placebo-controlled, multicentre trial of the oral anti-inflammatory medication called Colchicine on hospitalized COVID-19 patients. The stu...

BREAKING! India Approves 2-Deoxy-D-Glucose (2-DG) As An Adjuvant To Treat COVID-19 Patients And Reduce Supplemental Oxygen Dependence

Source: COVID-19 Drugs May 08, 2021 4 years ago

COVID-19 Drugs: About 3 hours ago, the Indian drug regulatory body, DCGI has granted emergency approval for the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad, as an adjuvant drug to treat hospitalized COVID-19 patients and also to reduce supplemental oxygen dependence. &n...

COVID-19 Drugs: Latest Japanese Study Shows Association Between High Serum Favipiravir Concentrations And Drug-Induced Liver Injury!

Source: COVID-19 Drugs May 06, 2021 4 years ago

COVID-19 Drugs: A new research by researchers from Japan shows that the teratogenic drug: Favipiravir that certain ignorant countries are using to treat COVID-19 can also induced liver injury if the serum concentration of the drug exceeds a certain threshold! The study findings were published on a preprint server and are currently being peer reviewed by teams from the United States ...

American Study Shows That Taking Low Dose Aspirin Decreases Risk Of Severity And Mortality When Infected With COVID-19

Source: Aspirin-COVID-19 Mar 21, 2021 4 years ago

A new study led by researchers from George Washington University and also included scientists from the University of Maryland, Wake Forest School of Medicine, Northeast Georgia Health System, Walter Reed National Military Medical Center, University of California-San Francisco and the University of Oklahoma School of Medicine have found that low dose aspirin may reduce the need for mechanical venti...

COVID-19 Antivirals: Japanese Study Shows That Oxidized Cholesterol Derivatives Or Oxysterol Shows Antiviral Activity Against SARS-CoV-2

Source: COVID-19 Antivirals Feb 04, 2021 4 years ago

COVID-19 Antivirals: Japanese researchers from National Institute of Infectious Diseases, Tokyo and the Tokyo University of Science have in a new study found that oxidized cholesterol derivatives or oxysterol exhibits potent antiviral activity against the SARS-Cov-2 coronavirus. Developments of effective antiviral drugs targeting SARS-CoV-2 are urgently needed to combat the COVID-19 disea...

COVID-19 Treatments: Taiwanese Study Finds That Zinc Supplements Enhances Certain Repurposed Drugs’ Efficacy Against SARS-CoV-2

Source: COVID-19 Treatments Feb 03, 2021 4 years ago

COVID-19 Treatments: A new study by researchers from National Taiwan University Hospital and National Taiwan University College of Medicine has found that zinc supplementation enhances the efficacy of certain repurposed drugs such as triclabendazole and emetine. The SARS-CoV-2 has caused vast number of infections and fatalities worldwide with almost 104 million infections and more than 2.25 milli...

COVID-19 Drugs: International Study Finds Colchicine Effective For Non-Hospitalized COVID-19 Patients

Source: COVID-19 Drugs Feb 01, 2021 4 years ago

COVID-19 Drugs: A new study by researchers from University of Montreal-Canada,New York University-USA, Universidad Autónoma de Madrid-Spain, Universidade de São Paulo-Brazil, Mayo Clinic-USA, San Francisco General Hospital-USA, Cedars-Sinai Heart Institute-USA And Université Laval-Canada has found that the existing anti-inflammatory oral drug drug-Colchicine could be rep...

COVID-19 Drugs: Cancer Drug Extracted From Sea Squirts, Aplidin, Effective Against SARS-CoV-2 Including B.1.1.7 Variant

Source: COVID-19 Drugs Jan 31, 2021 4 years ago

COVID-19 Drugs: Researchers from Emerging Pathogens Institute at Icahn School of Medicine at Mount Sinai and University of California-San Francisco’s Quantitative Bioscience Institute (QBI) have in a new study found a exsiting cancer drug called Aplidin effective against the SARS-CoV-2 coronavirus including the newly emergent B.1.1.7 variant. The cancer drug Aplidin is mad...

COVID-19 Antivirals: New International Study Shows That Carbon-Based Nanomaterials Could Function As Potential Antivirals To Treat COVID-19

Source: COVID-19 Antivirals Jan 31, 2021 4 years ago

COVID-19 Antivirals: A new international research involving scientist from Universidad Católica de Valencia-Spain, Kyoto University-Japan, University of Vienna-Austria, Pingla Thana Mahavidyalaya-India, Indian Statistical Institute-India, University of South Florida-USA, University of Otago-New Zealand, University of Padova-Italy, Yarmouk University-Jordan, CSIR-Indian Institute of Chemical...

Ivermectin Being Approved As Drug To Treat COVID-19 In More Countries Including Mexico, Brazil, Iran, India While South Africa Reverses Its Ban

Source: COVID-19 Drugs Jan 28, 2021 4 years ago

COVID-19 Drugs. While America and the United Kingdom along their so called ‘experts’ and corrupted politicians are constantly denouncing generic drugs that can be repurposed to treat COVID-19, supplements and herbs that can be used as adjuvants to also treat SARS-CoV-2 infections, more countries overseas are now beginning to accept ivermectin for use as both a prophylaxis and also as a...

COVID-19 Drugs: Italian Study Indicates That Diuretic Drug Ethacrynic Acid Could Be Repurposed To Treat COVID-19

Source: COVID-19 Drugs Jan 24, 2021 4 years ago

COVID-19 Drugs: Researchers from the University of Bari Aldo Moro-Italy and the University Campus Bio-Medico of Rome have in a new study found that the diuretic drug Ethacrynic Acid could be repurposed to treat COVID-19. The research findings are published in the peer reviewed journal: Viruses https://www.mdpi.com/1999-4915/13/1/106/htm The SARS-CoV-2 coronavirus, the causative ...

COVID-19 Drugs: New European Study Shows That Fenofibrate (Tricor) Exhibits Antiviral Properties Against SARS-CoV-2 Coronavirus

Source: COVID-19 Drugs Jan 14, 2021 4 years ago

COVID-19 Drugs: A new study by researchers from University of Birmingham-UK, Keele University-UK, San Raffaele Scientific Institute-Italy, University of Copenhagen-Denmark and the University of Liverpool-UK demonstrates that the drug called Fenofibrate exhibits antiviral properties against the SARS-CoV- coronavirus and could be repurposed to treat COVID-19. Fenofibrate, ...

Yet Another Randomized Trial Shows Efficacy Of Ivermectin To Treat COVID-19 But It Will Never Become Mainstream Due To Western Pharmaceutical Giants

Source: Ivermectin-COVID-19 Jan 12, 2021 4 years ago

Ivermectin-COVID-19: Indian researchers from the All India Institute of Medical Sciences have conducted a a double-blind, randomized, placebo-controlled clinical trial that demonstrated the efficacy of Ivermectin to treat COVID-19 disease. The clinical trial showed that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate COVID-19 patients. Ivermectin is currently being used ...

Commonly Used Blood Pressure Medications Such As ACE inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs) Safe For COVID-19 Patients

Source: Thailand Medical News Jan 08, 2021 4 years ago

A new international study lead by medical researchers from Perelman School of Medicine at the University of Pennsylvania has found that common medications used to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19. This study findings provides relief to many as during the initial phases of the COVID-19 pandemic, there were speculations that certain blood pr...

Pharma News: Azurrx Biopharma’s Proprietary Niclosamide Formulations To Treat COVID-19 Gastrointestinal Infections

Source: Pharma News Jan 05, 2021 4 years ago

Pharma News: Florida based AzurRx BioPharma, a company specializing in the development of non-systemic therapies for gastrointestinal (GI) diseases has announced that it has signed an exclusive worldwide licensing agreement with First Wave Bio, Inc for the use of their patented and proprietary oral and rectal formulations of niclosamide for the treatment of immune checkpoint inhibitor-as...

COVID-19 Drugs: Niclosamide Emerging As Another Potential Repurposed Drug Candidate To Treat COVID-19

Source: COVID-19 Drugs Dec 18, 2020 4 years ago

COVID-19 Drugs: The second wave of the COVID-19 pandemic is currently taking a toll on numerous countries around the world with daily global infection rates now surpassing 700,000 and daily COVID-19 deaths now exceeding 13,000 (On December 16th new records were reported with more than 725,950 COVID-19 infections in 24 hours and 13,558 COVID-19 deaths). As of Friday, (9am Bangkok time), th...

Yet Another Randomized Trial Shows Ivermectin Effectiveness To Treat COVID-19, This Time By Researchers From Clinica Universidad de Navarra-Spain

Source: Ivermectin and COVID-19 Dec 13, 2020 4 years ago

Ivermectin to treat COVID-19 in various stages of the disease is turning to be a more viable and proven option despite strong opposition from groups with vested interest in America and Europe.\ This time, a double blind, placebo- controlled randomized clinical trial tested the efficacy of the drug to treat mild conditions of the disease and to see how it prevents high viral loads, how it prevente...

COVID-19 Antivirals: Interim WHO Solidarity Trial Results Confirms That Remdesivir, Lopinavir And Interferon Have No Effect On COVID-19 Mortality

Source: COVID-19 Antivirals Dec 05, 2020 4 years ago

COVID-19 Antivirals: The interim WHO Solidarity Trial results confirms that antivirals like remdesivir, lopinavir, interferon and hydroxychloroquine seem to have little to no effect on mortality for hospitalized patients with COVID-19. The trial randomly assigned hospitalized patients with Covid-19 equally between one of the trial drug regimens that was locally available and open control ...

A Simple Guide To Supplements, Herbs and Repurposed Drugs That Can Help With COVID-19

Source: Supplements, Herbs and Repurposed Drugs For COVID-19 Dec 04, 2020 4 years ago

This simple guide to COVID-19 supplements, repurposed drugs and herbs that can help one with the COVID-19 is basically to help all around the world especially our readers in America, UK, the rest Of Europe, South America and India that has been badly affected by the COVID-19 pandemic and is going through a rough crisis in their countries.Please do due diligence first and never take any item below ...

Georgia State University Researchers Try To Peddle Mutagenic Drug Molnupiravir As Possible COVID-19 Therapeutic After Study On Ferrets!

Source: Molnupiravir Dec 04, 2020 4 years ago

Molnupiravir: As of the last count on Friday morning (4th December), sadly more than 276,120 Americans have died from the COVID-19 disease so far and more than 14.2 million COVID-19 infection cases were logged in the country. These figures are expected to rise exponentially in the next few months despite having so many ‘experts’ in the country. It was reported that resea...

BREAKING! Randomized Multi-Center Clinical Trial Shows That Ivermectin Is Effective To Treat COVID-19

Source: Nov 27, 2020 4 years ago

Ivermectin-COVID-19: Finally the results of a randomized trial has emerged to show the effectiveness of Ivermectin to treat COVID-19 despite numerous attempts by various big American and European pharmaceutical companies and their governments to try to suppress Ivermectin research due to greed and financial scams. The clinical trial study was led by Iranian researchers from Qazvin university of m...

Coronavirus News: French Study Shows That Antihypertensive Drugs Could Lower Risk Of Deaths In High Risk COVID-19 Patients

Source: Coronavirus News Nov 27, 2020 4 years ago

Coronavirus News: French researchers in a new multicenter study have found a lower or equal risk of fatal COVID-19 in hypertensive patients, depending on the type of medication they are on. The study finding confirms earlier recommendations that antihypertensives should be continued in these patients before and during infection with SARS-CoV-2, the viral agent that causes COVID-19. ...

American COVID-19 Scams: Infectious Diseases Society of America (IDSA) Warns Against Use Of U.S FDA Approved COVID-19 Drug Bamlanivimab

COVID-19 Scams Nov 24, 2020 4 years ago

American COVID-19 Scams: The Trump controlled U.S FDA, a regulatory agency that no longer has any credibility has suffered yet another blow as ethical medical professionals are advocating against the use of the overpriced drug bamlanivimab (Eli Lilly) that was granted emergency use authorization (EUA) by the U.S. FDA on the November 10th for use in ambulatory patients with mild to moderate COVID-1...

COVID-19 Scams: White House Controlled FDA Grants EUA Status To Regeneron’s Drug That Supposedly Costs About US$12,800 Per Treatment!

Source: COVID-19 Scams Nov 22, 2020 4 years ago

COVID-19 Scams: More emerging news coming out from the land of COVID-19 Scams-America. After the hydrochloroquinone, convalescent plasma and remdesivir sagas, we have the Eli lily monoclonal drug and now the Regeneron’s antibody cocktail drug being granted emergency authorization or EUA status to treat COVID-19. It was already expected news as many were sure that Trump has to oblige his...

COVID-19 Breakthrough! PANoptosis Discovered To Be Main Cause For Inflammation In COVID-19. TNF-alpha And IFN-gamma Blockers Can Help Treat COVID-19

Source: COVID-19 Breakthroughs Nov 20, 2020 4 years ago

COVID-19 Breakthroughs: A new breakthrough study led by researchers from St. Jude Children's Research Hospital-Memphis along with scientist from University of Tennessee Health Science Center have discovered that inflammation in COVID-19 patients were not just caused by cytokine storms per se or even just by bradykinin storms but rather were triggered by what is known as PANoptosis. PA...

Yet Another COVID-19 Prophylactic Intranasal Spray Debuting, This Time By University of Birmingham

Source: COVID-19 Intranasals Nov 20, 2020 4 years ago

COVID-19 Intranasals: Scientists from the University of Birmingham have developed a nasal spray that can provide effective protection against the SARS-CoV-2 coronavirus by using materials already cleared for use in humans. Airborne pathogens pose high risks in terms of both contraction and transmission within the respiratory pathways, in particular the nasal region. Although knowledge of ...

COVID-19 Scams: WHO Issues Warning Against Use Of Remdesivir For COVID-19. Countries Should Beware Of Any Therapeutics Approved In The USA!

Source: COVID-19 Scams Nov 20, 2020 4 years ago

COVID-19 Scams: Finally the world is seeing more day by day the scams perpetrated by American entities including the NIH, CDC, FDA, the Trump Administration and individuals like Dr Anthony Fauci, billionaires like Tom Cahill and politicians like Nick Ayers and Mike Spence. One of the biggest scams that is coming to light is remdesivir, an overpriced drug that had no efficacy against COVID...

COVID-19 Drugs: Taiwanese Study Shows That Therapeutics Targeting Neutrophils Can Treat ARDS In Severe COVID-19

Source: COVID-19 Drugs: Nov 16, 2020 4 years ago

COVID-19 Drugs: A new study by Taiwanese researchers from Chang Gung University, Kaohsiung Medical University, Chang Gung Memorial Hospital, Ming Chi University of Technology and Puxin Fengze Chinese Medicine Clinic have found that strategies using drugs and therapeutics to target neutrophils help to reduce and treat respiratory distress syndrome (ARDS) in severe COVID-19 patients. ...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 30 days ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 1 month ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 2 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 2 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 2 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 2 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 4 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 4 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 4 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 5 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 5 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 5 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 11 months ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 4 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 4 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 4 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 4 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 4 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 4 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 4 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 4 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 4 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 4 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

COVID-19 Research: Study From Columbia University Indicates That Lowering Testosterone Levels Could Reduce Severity Of COVID-19

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Uric Acid: Japanese Researchers Discover That High Uric Acid Levels Protects Against Lung Function Decline Especially In Older Women

Source: Uric Acid Supplements
Jun 07, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease

Source: COVID-19
May 28, 2020 5 years ago

COVID-19 Research: Could Disulfiram- A Drug To Prevent Alcoholism, Aid In Inhibiting Cytokine Storms In COVID-19?

Source: Covid-19 Research
May 26, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

COVID-19: Study Shows That COVID-19 Infections Could Lead To Delirium, PTSD and Other Psychiatric Disorders

Source: COVID-19 News
May 19, 2020 5 years ago

FROM COVID-19 DISINFECTANTS

LATEST ON REPRODUCTIVE MEDICINE

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM COVID-19 DISINFECTANTS

LATEST ON REPRODUCTIVE MEDICINE